HLB Pharmaceutical Co. Ltd (047920.KQ) stock: key figures, P/E, revenue and dividend

Energy · Coal & Consumable Fuels · South Korea · ISIN KR7047920004

Price
7,190.00 KRW
Market cap
255.91 bn KRW
P/E (2025)
55.98
P/S (2025)
1.24
Dividend yield
0.00 %
Net margin
2.22 %
Return on equity (ROE)
3.65 %
Return on assets (ROA)
2.68 %

HLB Pharmaceutical Co. Ltd financials

Fiscal year20242025
Revenue137.08 bn KRW205.58 bn KRW
Gross profit86.58 bn KRW106.50 bn KRW
Operating income-10.74 bn KRW1.06 bn KRW
EBIT1.79 bn KRW5.72 bn KRW
Net income2.02 bn KRW4.57 bn KRW
Diluted EPS – continuing operations66.63 KRW128.45 KRW

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About HLB Pharmaceutical Co. Ltd

HLB Pharmaceutical Co., Ltd. researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxant, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dental drugs, multivitamins, parasistic skin disese drugs, dermatlogicals, agents for urogenital organ, amino acid agent, antitussive, mucolytic agents, anthelmintics, antidiarrheals, circulatory system drug, vitamins, skin softeners, anti-hemorrhoid drugs, and agents for liver disease. It is also developing CTT-004 for the treatment of ataxia induced by spinocerebellar degeneration; and offers CMO services. The company was formerly known as Mediforum Pharmaceutical Incorporation and changed its name to HLB Pharmaceutical Co., Ltd in October 2020. HLB Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Namyangju-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.